A new combination of drugs has been found to delay the progression of advanced prostate cancer. The combination, which includes a drug called Talzenna, has shown significant promise in slowing the disease. Reports suggest that this therapy may offer a life-extending treatment option for men with advanced prostate cancer, potentially lowering the risk of death, although the exact details and outcomes are still emerging.